CpG motifs: the active ingredient in bacterial extracts?
Data up to Jan 2025
Total Citations Per Year
Abstract
References (75)
Innate Immune Recognition
2002 • 8,157 citations
A Toll-like receptor recognizes bacterial DNA
2000 • 6,348 citations
CpG motifs in bacterial DNA trigger direct B-cell activation
1995 • 3,543 citations
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 • 2,520 citations
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens
2001 • 1,989 citations
Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides
2002 • 1,919 citations
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 • 1,877 citations
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
2001 • 1,498 citations
Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling
2002 • 1,228 citations
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
1997 • 1,008 citations
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4
2002 • 985 citations
THE TREATMENT OF MALIGNAT TUMORS BY REPEATED INOCULATIONS OF ERYSIPELAS
1893 • 946 citations
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
1997 • 919 citations
The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.
1991 • 917 citations
Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells
2001 • 883 citations
The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors
2002 • 803 citations
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12
2001 • 798 citations
Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments
2002 • 724 citations
CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
1998 • 667 citations
Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo
2000 • 593 citations
Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.
1998 • 557 citations
Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells
2002 • 528 citations
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
1997 • 526 citations
Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets
2002 • 461 citations
Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
1994 • 430 citations
Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma
1998 • 416 citations
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
2002 • 410 citations
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
1998 • 402 citations
CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
1997 • 390 citations
CpG Motifs in Bacterial DNA Activate Leukocytes Through the pH-Dependent Generation of Reactive Oxygen Species
1998 • 331 citations
Antagonism of Immunostimulatory CpG-Oligodeoxynucleotides by Quinacrine, Chloroquine, and Structurally Related Compounds
1998 • 263 citations
Characterization of a new subpopulation of mouse CD8α+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential
2002 • 254 citations
Divergent Therapeutic and Immunologic Effects of Oligodeoxynucleotides with Distinct CpG Motifs
2001 • 252 citations
NK- and CD8+ T Cell-Mediated Eradication of Established Tumors by Peritumoral Injection of CpG-Containing Oligodeoxynucleotides
2001 • 213 citations
FDG–PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging
2002 • 206 citations
Uptake of Apoptotic Antigen-Coupled Cells by Lymphoid Dendritic Cells and Cross-Priming of CD8+ T Cells Produce Active Immune Unresponsiveness
2002 • 193 citations
Peritumoral CpG DNA Elicits a Coordinated Response of CD8 T Cells and Innate Effectors to Cure Established Tumors in a Murine Colon Carcinoma Model
2002 • 192 citations
CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
2000 • 191 citations
The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA
2003 • 178 citations
Do DNA Vaccines Induce Autoimmune Disease?
1997 • 178 citations
Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys
1999 • 172 citations
Bacterial CpG-DNA activates dendritic cellsin vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins
2000 • 163 citations
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
1998 • 158 citations
Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN
2000 • 157 citations
Induction of antigen-specific human CD4+ T cell anergy by peripheral blood DC2 precursors
2001 • 150 citations
CpG Are Efficient Adjuvants for Specific CTL Induction Against Tumor Antigen-Derived Peptide
2002 • 148 citations
Repeated Administration of Cytosine-Phosphorothiolated Guanine-Containing Oligonucleotides Together with Peptide/Protein Immunization Results in Enhanced CTL Responses with Anti-Tumor Activity
2000 • 145 citations
Postexposure prophylaxis against prion disease with a stimulator of innate immunity
2002 • 138 citations
Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.
2000 • 135 citations
How BCG Led to the Discovery of Immunostimulatory DNA
1999 • 128 citations
Immunostimulatory CpG Oligodeoxynucleotides Enhance the Immune Response to Vaccine Strategies Involving Granulocyte-Macrophage Colony-Stimulating Factor
1998 • 124 citations
CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma
2002 • 122 citations
Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy
2002 • 118 citations
Dendritic Cell Maturation and Subsequent Enhanced T-Cell Stimulation Induced with the Novel Synthetic Immune Response Modifier R-848
1999 • 116 citations
Immune Recognition of Foreign DNA
1999 • 116 citations
CpG Stimulation of Primary Mouse B Cells Is Blocked by Inhibitory Oligodeoxyribonucleotides at a Site Proximal to NF-κB Activation
2001 • 114 citations
Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines
1999 • 111 citations
CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
2003 • 107 citations
Priming MHC-I-Restricted Cytotoxic T Lymphocyte Responses to Exogenous Hepatitis B Surface Antigen Is CD4+ T Cell Dependent
1999 • 102 citations
Reduction of CpG‐induced arthritis by suppressive oligodeoxynucleotides
2002 • 90 citations
A role for Toll in autoimmunity
2002 • 82 citations
Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients
2001 • 80 citations
DNA and a CpG Oligonucleotide Derived fromBabesia bovisAre Mitogenic for Bovine B Cells
1998 • 80 citations
Antisense c-myc and Immunostimulatory Oligonucleotide Inhibition of Tumorigenesis in a Murine B-Cell Lymphoma Transplant Model
1998 • 79 citations
Immunostimulatory DNA Sequences Influence the Course of Adjuvant Arthritis
2002 • 78 citations
Innate Immune Responses to LCMV Infections: Natural Killer Cells and Cytokines
2002 • 74 citations
Eradication of disseminated lymphomas with CpG-DNA activated T helper type 1 cells from nontransgenic mice.
2000 • 72 citations
Vaccination with Tumor Peptide in CpG Adjuvant Protects Via IFN-γ-Dependent CD4 Cell Immunity
2002 • 69 citations
A hepatitis B vaccine formulated with a novel adjuvant system
2000 • 62 citations
Use of CpG DNA for Enhancing Specific Immune Responses
2000 • 57 citations
Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion
1999 • 52 citations
From A to Z on CpG
2002 • 52 citations
Avoiding Tolerance Against Prostatic Antigens With Subdominant Peptide Epitopes
2001 • 51 citations
Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation
2003 • 48 citations
Prevention of spontaneous mammary adenocarcinoma in HER‐2/neu transgenic mice by foreign DNA
2002 • 31 citations
Cited By (0)
No citing papers found in database